Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...
Abstract: This article reveals issues with operation of practical current source fed phase shift controlled semi-active rectifier (PS-ZVS SAR), often utilized as the output stage of resonant ...
Abstract: The wireless motor system has garnered significant interest in recent times. However, its efficiency is inevitably reduced due to the mismatch between the equivalent and optimal load ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback